SATRIX COLLECTIVE INVESTMENT SCHEME - Conversion Ratio And The Listing Of The Satrix Healthcare Innovation Feeder ETF ("The Portfolio") - STXHLT

Conversion Ratio And The Listing Of The Satrix Healthcare Innovation Feeder ETF ("The Portfolio") - STXHLT

SATRIX COLLECTIVE INVESTMENT SCHEME
SATRIX HEALTHCARE INNOVATION FEEDER ETF
JSE Code: STXHLT
ISIN: ZAE000310496
("Satrix Healthcare Innovation" or the "Portfolio")

A portfolio in the Satrix Collective Investment Scheme, registered as
such in terms of the Collective Investment Schemes Control Act, 45 of
2002

CONVERSION RATIO AND THE LISTING OF THE SATRIX HEALTHCARE INNOVATION
FEEDER ETF (“THE PORTFOLIO”)

Further to the announcement released on SENS on Friday, 20 May 2022
regarding the results of the initial public offer (“the offer”) for
subscription to the portfolio, Satrix Managers (RF) Pty Limited hereby
announce the conversion ratio and the listing of the portfolio.

1. Conversion ratio

Investors will be entitled to 0.0180661 (“the conversion ratio”)
Satrix Healthcare Innovation Securities for every letter of allocation
(“LA”) issued. The LAs will be converted to Satrix Healthcare
Innovation securities in the subscriber’s CSDP or broker account.

STRATE will convert the LA to Satrix securities in the subscriber’s
CSDP or broker accounts in terms of the conversion ratio above.


2. Issued securities and listing

Satrix Healthcare Innovation Feeder ETF will issue 176 811(One hundred
and seventy six thousand eight hundred and eleven) securities to list
on the “Exchange Traded Funds” sector of the main board of the JSE
Limited, at an issue price of approximately R 55.35 per security, to
commence trading on Thursday, 26 May 2022.




23 May 2022

Satrix Managers (RF) Pty Limited


JSE Sponsors
Vunani

Date: 23-05-2022 05:15:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.